Video journal goes closed access

The__ linkurl:Journal of Visualized Experiments;http://www.jove.com __(JoVE), the first life sciences video methods journal, moved from an open access publishing model to paid subscription status last week (Apr. 2) in order to cover its costs of operations. The journal, which has released more 300 video-protocol "articles," had been open access since its launch in October 2006. But citing the higher than usual costs associated with video production and the supporting technological infrastructur

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The__ linkurl:Journal of Visualized Experiments;http://www.jove.com __(JoVE), the first life sciences video methods journal, moved from an open access publishing model to paid subscription status last week (Apr. 2) in order to cover its costs of operations.
The journal, which has released more 300 video-protocol "articles," had been open access since its launch in October 2006. But citing the higher than usual costs associated with video production and the supporting technological infrastructure, JoVE quietly announced its change in business model through the blogosphere on Apr. 1 -- a day before the change took effect. "To continue the [open access] approach, we would have to ask academic labs to pay us $6000 per video to cover our operation costs, and that's simply not possible today," linkurl:Moshe Pritsker,;http://www.jove.com/index/Team.stp CEO and editor-in-chief of JoVE, told __The Scientist__. "We like open access, we just can't survive on it." JoVE is now selling institutional linkurl:subscriptions;http://www.jove.com/index/Subscribe.stp that range from $1,000 per year for small colleges to $2,400 per year for large research universities. Pritsker said that "up to 10" institutions had signed up in the past week, including Harvard University, Wellesley College, and the University of California, Davis. Individuals can also buy $19 daily and $99 monthly subscriptions, as well as obtain free one-day trial access. Pritsker expects JoVE to have 300 to 400 institutional subscribers within three years, which would represent a "pull even situation," he said. The journal will continue to charge $1,500 in author fees, although researchers can pay an extra $1,500 to make their publications freely and openly available. "I can't say I'm terribly surprised," David Crotty, the executive editor of linkurl:Cold Spring Harbor Protocols,;http://cshprotocols.cshlp.org/ wrote on his linkurl:Bench Marks;http://www.cshblogs.org/cshprotocols/2009/04/02/jove-ends-open-access/ blog. "JoVE set themselves a monumental task, trying to break ground with a new type of science publishing and at the same time trying to do so with an unproven business model. Doing both together was perhaps a bit too ambitious."
**__Related stories:__***linkurl:Online methods videos go mainstream;http://www.the-scientist.com/blog/display/54364/
[22nd February 2008]*linkurl:Online videos catch on;http://www.the-scientist.com/news/display/53500/
[22nd August 2007]*linkurl:Ready for your closeup?;http://www.the-scientist.com/blog/display/37167/
[4th December 2006]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies